Jeffrey Frank, MD
Neurology with Special Qualifications in Child Neurology · Springfield, ORNPI 1023246600
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $45,307 of the $59,317 with a category attached, or 76.4%. Jazz Pharmaceuticals Inc. accounts for 98.2% of it on its own, with 27 other manufacturers making up the rest.
Across 113 payments — averaging $524.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$58K
- AbbVie$226
- AstraZeneca$96
- Greenwich Biosciences, Inc.$83
- Aquestive Therapeutics, Inc.$66
- Bristol Myers Squibb$56
- plus $555 from 22 others
Across 14 payments — averaging $2513.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Upsher-smith Laboratories LLC$20K
- UCB Biosciences Inc.$15K
What the payments were for
- Consulting fees$5,2809%
- Speaking & faculty fees$45,30776%
- Travel & lodging$6,45011%
- Food & beverage$2,2814%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 60 | $58,235 |
| AbbVie(2 entities) | 9 | $226 |
| AstraZeneca | 5 | $96 |
| Greenwich Biosciences, Inc. | 4 | $83 |
| Aquestive Therapeutics, Inc. | 4 | $66 |
| Bristol Myers Squibb | 3 | $56 |
| Sanofi | 2 | $51 |
| Teva Pharmaceuticals USA, Inc. | 3 | $46 |
| Neuropace, Inc. | 2 | $40 |
| Acorda Therapeutics, Inc | 2 | $37 |
| Advanced Respiratory, Inc | 1 | $36 |
| UCB, Inc. | 2 | $36 |
| Cala Health, Inc. | 1 | $30 |
| Argenx US, Inc. | 1 | $28 |
| Merz Pharmaceuticals, LLC | 1 | $27 |
| Nalu Medical, Inc. | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Sarepta Therapeutics, Inc. | 1 | $20 |
| Immedica Pharma US, Inc. | 1 | $19 |
| SK Life Science, Inc. | 1 | $17 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Boston Scientific | 1 | $16 |
| Novartis | 1 | $14 |
| Genentech USA, Inc. | 1 | $12 |
| Zogenix Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Epidiolex$56,698
How this compares
Too few neurology with special qualifications in child neurology providers in Oregonto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EpidiolexCannabidiol (Cbd) | 19 | $103,251 |
| Lamotrigine ErLamotrigine | 15 | $10,641 |
| Lacosamide | 26 | $2,740 |
| Levetiracetam | 33 | $1,812 |
| Carbamazepine ErCarbamazepine | 23 | $1,549 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 29 | $1,381 |
| Levetiracetam ErLevetiracetam | 11 | $1,031 |
| Clobazam | 16 | $938 |
| Zonisamide | 20 | $788 |
| Trazodone Hcl | 13 | $686 |
| Primidone | 20 | $566 |
| Gabapentin | 20 | $470 |
| Propranolol Hcl ErPropranolol Hcl | 13 | $433 |
| Topiramate | 20 | $432 |
| Clonazepam | 15 | $403 |
Paid to pharmacies, not to this prescriber.
Other neurology with special qualifications in child neurology in Springfield
- Erika FinangerPortland$165K
- Colin RobertsPortland$19K
- Stephen BackPortland$3K
- Joshua KimPortland$3K
- Alison ChristyPortland$2K
- Barry RussmanPortland$2K
- Austin LaytonPortland$906
- Jennifer HuffmanPortland$552
- Juan PiantinoPortland$368
- Donald OlsonMedford$320
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.